Search

Your search keyword '"Sheehan, Katherine"' showing total 314 results

Search Constraints

Start Over You searched for: Author "Sheehan, Katherine" Remove constraint Author: "Sheehan, Katherine"
314 results on '"Sheehan, Katherine"'

Search Results

4. Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservation.

5. Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservation

6. 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report

7. Donepezil Nanoemulsion Induces a Torpor-like State with Reduced Toxicity in Nonhibernating Xenopus laevisTadpoles

8. Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

9. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis

10. Cover Image, Volume 43, Issue 5

12. MP17-08 CLINICAL VALIDATION OF A NOVEL SIX-GENE RISK-STRATIFICATION SIGNATURE TO SUPPORT TREATMENT DECISIONS FOR MEN DIAGNOSED WITH PROSTATE CANCER

13. Supplementary Methods from The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer

14. Data from The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer

15. Supplementary Tables 1-2 from The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer

16. Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservation

17. Development and clinical validation of a novel biopsy-based six-gene signature to accurately risk-stratify men with early-stage prostate cancer to aid treatment decision making.

19. Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer

21. Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue

23. Assessment of tumour infiltrating subpopulations and pathological complete response using multiplex immunohistochemistry and digital pathology in early HER2+ breast cancer.

24. AB069. SOH22ABS209. The epitranscriptomic landscape in estrogen receptor (ER)-positive breast cancer disease progression

25. Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression

27. The Frequencies and Clinical Implications of Mutations in 33 Kinase-Related Genes in Locally Advanced Rectal Cancer: A Pilot Study

28. Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors

29. 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report

30. Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy

31. Additional file 1 of Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

33. Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase

35. Expression of active p21-activated kinase-1 induces [Ca.sup.2+] flux modification with altered regulatory protein phosphorylation in cardiac myocytes

36. Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers

37. Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1

39. p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility

41. Palytoxin disrupts cardiac excitation-contraction coupling through interactions with P-type ion pumps

44. Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

45. Abstract P1-10-13: Examination of CCL26, CCL17 and CCL19 chemokines as biomarkers in HER2+ breast cancer (BC) in the neo-adjuvant setting

46. Caring for Justice.

Catalog

Books, media, physical & digital resources